Editorial: Body fluid biomarkers in neurodegenerative studies: Novel insights into pathophysiology to support clinical practice and drug development
- PMID: 36733314
- PMCID: PMC9887318
- DOI: 10.3389/fneur.2023.1103116
Editorial: Body fluid biomarkers in neurodegenerative studies: Novel insights into pathophysiology to support clinical practice and drug development
Keywords: Alzheimer's disease (AD); Parkinson's disease (PD); biomarkers; neurodegeneration; pathophysiology.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Body fluid biomarkers in neurodegenerative studies: Novel insights into pathophysiology to support clinical practice and drug development
References
-
- Lacorte E, Ancidoni A, Zaccaria V, Remoli G, Tariciotti L, Bellomo G, et al. Safety and efficacy of monoclonal antibodies for Alzheimer's disease: a systematic review and meta-analysis of published and unpublished clinical trials. J Alzheimers Dis. (2022) 87:101–29. 10.3233/JAD-220046 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
